{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:01:05Z","timestamp":1791165665010,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejpb.2024.114504","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:09:54Z","timestamp":1726726194000},"page":"114504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Hydrophobic solid lipid-based microparticles for the protection of gastric-sensitive hydrophilic active biomolecules for oral administration in the treatment of EPI"],"prefix":"10.1016","volume":"204","author":[{"given":"Alexis","family":"Bages","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"Castelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Raynal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Ioualalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejpb.2024.114504_b0005","first-page":"523","article-title":"State of the Art in Exocrine Pancreatic Insufficiency","volume":"56","author":"Di\u00e9guez-Castillo","year":"2020","journal-title":"Med. Kaunas Lith."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114504_b0010","first-page":"238","article-title":"The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis","volume":"13","author":"Sikkens","year":"2013","journal-title":"Pancreatol. off. J. Int. Assoc. Pancreatol. IAP Al"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114504_b0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/00365520510023116","article-title":"Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study","volume":"40","author":"Rothenbacher","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"issue":"39","key":"10.1016\/j.ejpb.2024.114504_b0020","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.3748\/wjg.v23.i39.7059","article-title":"Less common etiologies of exocrine pancreatic insufficiency","volume":"23","author":"Singh","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114504_b0025","first-page":"305","article-title":"Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis","volume":"12","author":"Lindkvist","year":"2012","journal-title":"Pancreatol. off. J. Int. Assoc. Pancreatol. IAP Al"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114504_b0030","first-page":"71","article-title":"Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey","volume":"12","author":"Sikkens","year":"2012","journal-title":"Pancreatol. off. J. Int. Assoc. Pancreatol. IAP Al"},{"issue":"42","key":"10.1016\/j.ejpb.2024.114504_b0035","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.3748\/wjg.v19.i42.7258","article-title":"Diagnosis and treatment of pancreatic exocrine insufficiency","volume":"19","author":"Lindkvist","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2024.114504_b0040","first-page":"55","article-title":"Enzyme replacement therapy for pancreatic insufficiency: present and future","volume":"4","author":"Fieker","year":"2011","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"44","key":"10.1016\/j.ejpb.2024.114504_b0045","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.3748\/wjg.v19.i44.7930","article-title":"Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas","volume":"19","author":"Pezzilli","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114504_b0050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0300-9084(71)80146-3","article-title":"La lipase pancr\u00e9atique","volume":"53","author":"Desnuelle","year":"1971","journal-title":"Biochimie"},{"issue":"4 Pt 1","key":"10.1016\/j.ejpb.2024.114504_b0055","first-page":"G475","article-title":"Fate of pancreatic enzymes during small intestinal aboral transit in humans","volume":"251","author":"Layer","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejpb.2024.114504_b0060","first-page":"pp. vi1-28","article-title":"Human pancreatic exocrine response to nutrients in health and disease","volume":"vol. 54 Suppl 6, no. Suppl 6","author":"Keller","year":"2005","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114504_b0065","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/gut.2006.094912","article-title":"Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to gastric coated pancreatic extracts","volume":"55","author":"Dom\u00ednguez-Mu\u00f1oz","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114504_b0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/03639040802422104","article-title":"Preparation and in vivo efficacy study of pancreatin microparticles as an enzyme replacement therapy for pancreatitis","volume":"35","author":"Naikwade","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"33","key":"10.1016\/j.ejpb.2024.114504_b0075","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.3748\/wjg.v20.i33.11467","article-title":"Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century","volume":"20","author":"Trang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114504_b0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0939-6411(00)00089-8","article-title":"Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs","volume":"50","author":"Gershanik","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114504_b0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.addr.2007.09.006","article-title":"Approaches for the development of solid and semi-solid lipid-based formulations","volume":"60","author":"Jannin","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2024.114504_b0090","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114504_b0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.apsb.2013.10.001","article-title":"Oral lipid-based drug delivery systems \u2013 an overview","volume":"3","author":"Kalepu","year":"2013","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114504_b0100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1208\/s12248-016-0036-6","article-title":"Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion","volume":"19","author":"Vithani","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2024.114504_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121958","article-title":"Controlling drug release by introducing lipase inhibitor within a lipid formulation","volume":"623","author":"Murshed","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114504_b0110","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s13346-021-00908-7","article-title":"Lozano, \u201cCurrent approaches in lipid-based nanocarriers for oral drug delivery\u201d","volume":"11","author":"Plaza-Oliver","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114504_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5173(93)90222-2","article-title":"An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis","volume":"96","author":"Craig","year":"1993","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114504_b0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0378-5173(94)90271-2","article-title":"Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs","volume":"106","author":"Shah","year":"1994","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114504_b0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-5173(86)90043-8","article-title":"The oral absorption of cefoxitin from oil and emulsion vehicles in rats","volume":"33","author":"Palin","year":"1986","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114504_b0130","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2217\/nnm.16.9","article-title":"Recent advances in liposome surface modification for oral drug delivery","volume":"11","author":"Nguyen","year":"2016","journal-title":"Nanomed."},{"key":"10.1016\/j.ejpb.2024.114504_b0135","article-title":"Formulation gastroprotectrice de complexes d\u2019enzymes permettant de restaurer la fonction digestive","volume":"17","author":"Ioualalen","year":"2020","journal-title":"FR3079146B1"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114504_b0140","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/ijms23062940","article-title":"The Study of Protein-Cyclitol Interactions","volume":"23","author":"Dyrda-Terniuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114504_b0145","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/jps.20625","article-title":"BSA Degradation Under Acidic Conditions: A Model For Protein Instability During Release From PLGA Delivery Systems","volume":"95","author":"Estey","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114504_b0150","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.4315\/0362-028X-66.11.2076","article-title":"Protection of Bifidobacteria Encapsulated in Polysaccharide-Protein Gel Beads against Gastric Juice and Bile","volume":"66","author":"Guerin","year":"2003","journal-title":"J. Food Prot."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114504_b0155","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00018-013-1388-z","article-title":"\u03b1-Amylase: an enzyme specificity found in various families of glycoside hydrolases","volume":"71","author":"Jane\u010dek","year":"2014","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"6","key":"10.1016\/j.ejpb.2024.114504_b0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/bjs.1800650613","article-title":"Amylase thermolability as a screening test for pancreatic pseudocysts","volume":"65","author":"Donaldson","year":"1978","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114504_b0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0009-8981(96)06316-4","article-title":"Thermostability of purified human pancreatic \u03b1-amylase is increased by the combination of Ca2+ and human serum albumin","volume":"252","author":"Tessier","year":"1996","journal-title":"Clin. Chim. Acta"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T19:07:46Z","timestamp":1729710466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124003308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"alternative-id":["S0939641124003308"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114504","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrophobic solid lipid-based microparticles for the protection of gastric-sensitive hydrophilic active biomolecules for oral administration in the treatment of EPI","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114504"}}